Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America Guideline Committee.

[1]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[2]  G. Boriani,et al.  Cost-effectiveness of cardiac resynchronisation therapy , 2012, Heart.

[3]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[4]  K. Dickstein,et al.  The European Cardiac Resynchronization Therapy Survey: comparison of outcomes between de novo cardiac resynchronization therapy implantations and upgrades , 2011, European journal of heart failure.

[5]  A. Moss,et al.  Reduction of the risk of recurring heart failure events with cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy). , 2011, Journal of the American College of Cardiology.

[6]  D. Simon,et al.  Effect of QRS Morphology on Clinical Event Reduction With Cardiac Resynchronization Therapy: Meta-Analysis of Randomized Controlled Trials , 2011 .

[7]  J. Daubert,et al.  Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction). , 2011, European heart journal.

[8]  A. Capucci,et al.  Long-Term Complications Related to Biventricular Defibrillator Implantation: Rate of Surgical Revisions and Impact on Survival Insights From the Italian ClinicalService Database , 2011, Circulation.

[9]  J. Curtis,et al.  Implantable Cardioverter-Defibrillator Registry Risk Score Models for Acute Procedural Complications or Death After Implantable Cardioverter-Defibrillator Implantation , 2011, Circulation.

[10]  L. Epstein,et al.  Event‐Free Survival Following CRT with Surgically Implanted LV Leads Versus Standard Transvenous Approach , 2011, Pacing and clinical electrophysiology : PACE.

[11]  Eugene Crystal,et al.  Predictors of Short-Term Complications After Implantable Cardioverter-Defibrillator Replacement: Results From the Ontario ICD Database , 2011, Circulation. Arrhythmia and electrophysiology.

[12]  Wojciech Zareba,et al.  Left Ventricular Lead Position and Clinical Outcome in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT) Trial , 2011, Circulation.

[13]  Paul J. Wang,et al.  Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT) , 2011, Circulation.

[14]  F. McAlister,et al.  Meta-analysis: Cardiac Resynchronization Therapy for Patients With Less Symptomatic Heart Failure , 2011, Annals of Internal Medicine.

[15]  J. Healey,et al.  Cardiac resynchronization therapy: a meta-analysis of randomized controlled trials , 2011, Canadian Medical Association Journal.

[16]  S. Solomon,et al.  Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial. , 2011, Journal of the American College of Cardiology.

[17]  W. Tang,et al.  Cardiac Resynchronization Therapy in Patients With Class I–II Heart Failure and a Wide QRS: A Cautionary Note , 2011, Circulation.

[18]  M. Gold,et al.  Should Cardiac Resynchronization Therapy Be Used in Patients With Class I-II Heart Failure and a Wide QRS? Cardiac Resynchronization Therapy for Mild Heart Failure The Time Has Come , 2011 .

[19]  J. Gorcsan.  Finding pieces of the puzzle of nonresponse to cardiac resynchronization therapy. , 2011, Circulation.

[20]  JohnGorcsan.  Finding Pieces of the Puzzle of Nonresponse to Cardiac Resynchronization Therapy , 2011 .

[21]  Finn Gustafsson,et al.  2010 Focused Update of ESC Guidelines on Device Therapy in Heart Failure , 2011 .

[22]  M. Gold.  Complication Rates Associated With Pacemaker or Implantable Cardioverter-Defibrillator Generator Replacements and Upgrade Procedures: Results From the REPLACE Registry , 2011 .

[23]  M. Gold,et al.  Cardiac resynchronization therapy for mild heart failure: the time has come. , 2011, Circulation.

[24]  Suneet Mittal,et al.  Primary Results From the SmartDelay Determined AV Optimization: A Comparison to Other AV Delay Methods Used in Cardiac Resynchronization Therapy (SMART-AV) Trial: A Randomized Trial Comparing Empirical, Echocardiography-Guided, and Algorithmic Atrioventricular Delay Programming in Cardiac Resynchron , 2010, Circulation.

[25]  John L Sapp,et al.  Cardiac-resynchronization therapy for mild-to-moderate heart failure. , 2010, The New England journal of medicine.

[26]  J. Curtis,et al.  Acute lead dislodgements and in-hospital mortality in patients enrolled in the national cardiovascular data registry implantable cardioverter defibrillator registry. , 2010, Journal of the American College of Cardiology.

[27]  J Taylor,et al.  Focused update of the ESC Guidelines on device therapy in heart failure. , 2010, European heart journal.

[28]  M. Josephson,et al.  Three Questions for Evidence-Based Cardiac Electrophysiology , 2010, Circulation. Cardiovascular quality and outcomes.

[29]  M. Chung,et al.  Complication Rates Associated With Pacemaker or Implantable Cardioverter-Defibrillator Generator Replacements and Upgrade Procedures: Results From the REPLACE Registry , 2010, Circulation.

[30]  David M Kent,et al.  Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal , 2010, Trials.

[31]  G. Fonarow,et al.  Improving Evidence-Based Care for Heart Failure in Outpatient Cardiology Practices: Primary Results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF) , 2010, Circulation.

[32]  Nancy M Albert,et al.  HFSA 2010 Comprehensive Heart Failure Practice Guideline. , 2010, Journal of cardiac failure.

[33]  Wojciech Zareba,et al.  Cardiac-resynchronization therapy for the prevention of heart-failure events. , 2009, The New England journal of medicine.

[34]  M. Jessup.  MADIT-CRT--breathtaking or time to catch our breath? , 2009, The New England journal of medicine.

[35]  G. Maurer,et al.  Outcome after device implantation in chronic heart failure is dependent on concomitant medical treatment , 2009, European journal of clinical investigation.

[36]  M. Gold,et al.  Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial. , 2009, Journal of the American College of Cardiology.

[37]  F. Ruschitzka,et al.  Cardiac resynchronization therapy in patients with a narrow QRS , 2009, Current heart failure reports.

[38]  Wilfried Mullens,et al.  Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program. , 2009, Journal of the American College of Cardiology.

[39]  Stefano Ghio,et al.  Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. , 2008, Journal of the American College of Cardiology.

[40]  T. Marwick,et al.  The riddle of determining cardiac resynchronization therapy response a physiologic approach to dyssynchrony therapy. , 2008, Journal of the American College of Cardiology.

[41]  Michael Böhm,et al.  Kommentar zu den ESC-Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 , 2008, European journal of heart failure.

[42]  T. Abraham,et al.  Is echocardiographic assessment of dyssynchrony useful to select candidates for cardiac resynchronization therapy? Echocardiography is useful before cardiac resynchronization therapy if QRS duration is available. , 2008, Circulation. Cardiovascular imaging.

[43]  Frits W Prinzen,et al.  Echocardiography Is Not Useful Before Cardiac Resynchronization Therapy if QRS Duration Is Available , 2008, Circulation. Cardiovascular imaging.

[44]  Jeroen J. Bax,et al.  Results of the Predictors of Response to CRT (PROSPECT) Trial , 2008, Circulation.

[45]  P. Tchou,et al.  Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. , 2007, The New England journal of medicine.

[46]  Ben Vandermeer,et al.  Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. , 2007, JAMA.

[47]  Jagmeet P. Singh,et al.  Left ventricular lead electrical delay predicts response to cardiac resynchronization therapy. , 2006, Heart rhythm.

[48]  Richard Sutton,et al.  Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure , 2006, Heart.

[49]  Nick Freemantle,et al.  Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. , 2006, European heart journal.

[50]  David L Hayes,et al.  Sustained Reverse Left Ventricular Structural Remodeling With Cardiac Resynchronization at One Year Is a Function of Etiology: Quantitative Doppler Echocardiographic Evidence From the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) , 2006, Circulation.

[51]  A. Owen.  Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial. , 2005, European heart journal.

[52]  D. Kass,et al.  Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial. , 2005, Journal of the American College of Cardiology.

[53]  I. Piña,et al.  Clinical and analytical considerations in the study of health status in device trials for heart failure. , 2005, Journal of cardiac failure.

[54]  A. Hoes,et al.  Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.

[55]  J. Daubert,et al.  The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.

[56]  J. Daubert,et al.  Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial. , 2006, European heart journal.

[57]  D. Burkhoff,et al.  Development and validation of a patient questionnaire to determine New York Heart Association classification. , 2004, Journal of cardiac failure.

[58]  D. DeMets,et al.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.

[59]  E. Foster,et al.  Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. , 2003, Journal of the American College of Cardiology.

[60]  R. Canby,et al.  Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. , 2003, JAMA.

[61]  Milton Packer,et al.  Cardiac resynchronization in chronic heart failure. , 2002, The New England journal of medicine.

[62]  P. McCullough,et al.  Congestive heart failure and QRS duration: establishing prognosis study. , 2002, Chest.

[63]  Vera Bittner,et al.  Validity and reliability of the NYHA classes for measuring research outcomes in patients with cardiac disease. , 2002, Heart & lung : the journal of critical care.

[64]  Stefan Sack,et al.  Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. , 2002, Journal of the American College of Cardiology.

[65]  D. Delurgio,et al.  Cardiac resynchronization in chronic heart failure. , 2002, The New England journal of medicine.

[66]  Thomas Lavergne,et al.  Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay , 2001 .

[67]  N. Patel,et al.  How many people with heart failure are appropriate for biventricular resynchronization? , 2000, European heart journal.

[68]  J. Spertus,et al.  Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. , 2000, Journal of the American College of Cardiology.

[69]  J. Cohn,et al.  Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo. , 1993, The American journal of cardiology.